Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04858269
Title First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wake Forest University Health Sciences
Indications

oral squamous cell carcinoma

oropharynx cancer

laryngeal squamous cell carcinoma

Therapies

Carboplatin + Paclitaxel + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.